sofidexFor patientsAre you a clinician? Clinical site

Meds & supplements  ›  Vilanterol

Medicine

Vilanterol

The following clinically significant adverse reactions are described elsewhere in labeling:

Prescribing label

Selected manufacturer label information, organised into consistent sections by Sofidex. This source is written for healthcare professionals; ask your pharmacist to explain instructions that are unclear. Read the full label at DailyMed ↗

Drug facts

Used for
The following clinically significant adverse reactions are described elsewhere in labeling:
Do not take if
  • Primary treatment of status asthmaticus or other acute episodes of COPD or asthma where intensive measures are required.
  • Severe hypersensitivity to milk proteins or demonstrated hypersensitivity to fluticasone furoate, vilanterol, or any of the excipients.

Side effects, and when to stop

  • Serious Asthma-Related Events – Hospitalizations, Intubations, Death
  • Oropharyngeal Candidiasis
  • Pneumonia
  • Immunosuppression and Risk of Infections
  • Hypercorticism and Adrenal Suppression
  • Paradoxical Bronchospasm
  • Cardiovascular Effects
  • Reduction in Bone Mineral Density
  • Growth Effects
  • Glaucoma and Cataracts

Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared with rates in the clinical trials of another drug and may not reflect the rates observed in practice.

Who should not take it

BREO ELLIPTA is contraindicated in the following conditions:

  • Primary treatment of status asthmaticus or other acute episodes of COPD or asthma where intensive measures are required.
  • Severe hypersensitivity to milk proteins or demonstrated hypersensitivity to fluticasone furoate, vilanterol, or any of the excipients.

Cite this page

NLM

sofidex [Internet]. Daloreum; c2026. Vilanterol; [reviewed 2026 Aug 3; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/vilanterol

APA 7th

sofidex. (2026, August 3). Vilanterol. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/vilanterol

AMA 11th

Vilanterol. sofidex. Reviewed August 3, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/vilanterol

The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.